Photo from archive.org
Rovalpituzumab tesirine is well tolerated and has single-agent antitumor activity. Click to show full abstract
Rovalpituzumab tesirine is well tolerated and has single-agent antitumor activity.
Keywords:
patients dll3;
positive tumors;
rovalpituzumab tesirine;
dll3 positive;
tesirine active;
active patients
Journal Title: Cancer discovery
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer discovery
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!